Wuhan Keqian Biology Co.,Ltd (SHA:688526)

Market Cap	6.06B -18.6%
Revenue (ttm)	932.09M -5.1%
Net Income	389.72M -3.4%
EPS	0.84 -3.7%
Shares Out	463.92M
PE Ratio	15.55
Forward PE	12.74
Dividend	0.64 (4.82%)
Ex-Dividend Date	May 26, 2026

Volume	1,074,326
Open	13.27
Previous Close	13.27
Day's Range	13.01 - 13.27
52-Week Range	12.77 - 20.39
Beta	0.50
Analysts	Strong Buy
Price Target	18.50 (+41.65%)
Earnings Date	Aug 25, 2026

About SHA:688526

Wuhan Keqian Biology Co.,Ltd focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China. It offers vaccines for pigs, poultry, and pets, as well as diagnostic reagents. Wuhan Keqian Biology Co.,Ltd was founded in 2001 and is based in Wuhan, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 950
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688526

Financial Performance

In 2025, SHA:688526's revenue was 949.74 million, an increase of 0.83% compared to the previous year's 941.92 million. Earnings were 418.72 million, an increase of 9.51%.

Analyst Summary

According to 2 analysts, the average rating for 688526 stock is "Strong Buy." The 12-month stock price target is ¥18.50, which is an increase of 41.65% from the latest price.

Price Target

¥18.50

(41.65% upside)

Analyst Consensus: Strong Buy